Lahey Health is now part of Beth Israel Lahey Health.  Explore Lahey locations below or reach Lahey Hospital & Medical Center, Beverly Hospital and Winchester Hospital.

[LCID Study Number: 2018-013CIRB]

NRG-HN004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin.

The purpose of this study is to compare any good and bad effects of usual radiation plus the study treatment, MEDI4736 (durvalumab), to the usual therapy of radiation plus cetuximab in patients with head and neck cancer who cannot take the drug cisplatin.

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-3055